Reuters logo
8 months ago
BRIEF-Horizon Pharma announces availability of quinsair in Canada for treatment of specific lung infections
December 22, 2016 / 12:16 PM / 8 months ago

BRIEF-Horizon Pharma announces availability of quinsair in Canada for treatment of specific lung infections

Dec 22 (Reuters) - Horizon Pharma Plc

* Horizon Pharma PLC announces availability of quinsair (levofloxacin inhalation solution) in Canada for the treatment of specific lung infections in adults with cystic fibrosis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below